SRI International's Bioscience Division is seeking a creative, integrative thinker who is driven to use cutting edge approaches to advance early development, preclinical pharmacology and translational medicine. Reporting to the Bioscience Division President, this individual will provide scientific leadership to develop and execute impactful preclinical pharmacology and toxicology. This role requires experience in preclinical drug development within a pharmaceutical, CRO, and/or government lab environment. The successful candidate will be responsible for providing expertise for nonclinical and clinical development plans across multiple drug classes and indications. Applicants should have a strong track record of scientific and collaborative leadership with proven ability to manage a diverse team and provide strategic leadership for a dynamic portfolio. We are particularly interested in candidates with expertise in next-generation preclinical drug development technologies. Research experience in the following areas: In vitro systems such as organoids, organ chips, and/or microphysiology systems AI/ML platforms for in silico preclinical studies, for example, ADME profile modeling and optimization, toxicity modeling and assessment, virtual animal models, AI driven digital pathology and/or predictive models for safety endpoints for drug safety Pharmacology in precision medicine such as pharmacogenetics, biomarkers to guide drug development through integrating bench to patient research, and data-driven mechanism-indication pairing.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Industry
Professional, Scientific, and Technical Services
Education Level
Ph.D. or professional degree